When it comes to testing their potential to cause reproductive and developmental harm, oligonucleotide-based therapeutics present unique challenges. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in iNucleic Acid Therapeutics/i, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available free on the iNucleic ...
Read More
No comments:
Post a Comment